Characterization of a structurally tricistronic gene of human cytomegalovirus composed of U(s)18, U(s)19, and U(s)20. by Guo, Yaw-Wen & Huang, Eng-Shang
JOURNAL OF VIROLOGY, Apr. 1993, p. 2043-2054
0022-538X/93/042043-12$02.00/0
Copyright © 1993, American Society for Microbiology
Characterization of a Structurally Tricistronic Gene of Human
Cytomegalovirus Composed of Us18, Us19, and Us20
YAW-WEN GUO' AND ENG-SHANG HUANG' 2,3,4*
Curiculum of Genetics, 1 Department of Medicine,2 Department ofMicrobiology and Immunology,3
and Lineberger Comprehensive Cancer Center,4 University ofNorth Carolina
at Chapel Hill, Chapel Hill, North Carolina 27599-7295
Received 22 October 1992/Accepted 16 December 1992
A tricistronic gene mapped between 0.91 and 0.93 map units within the EcoRI D fragment of the human
cytomegalovirus unique short region (Us) has been cloned, sequenced, and expressed in vitro. Cloned cDNAs
of 2.3, 1.8, and 1.1 kb derived from this region were isolated from a Agtll cDNA library made from
virus-infected fibroblasts and used for this study. Two major classes of 3'.coterminal mRNAs, 2.8 and 1.1 kb,
were transcribed from this region. Sequence analysis of the cDNAs and the upstream genomic DNA revealed
three open reading frames (ORFs), Us18, Us19, and Us20, and a common polyadenylation signal located 15
bases upstream of the poly(A) tail of both the 2.85- and 1.1-kb mRNAs. Protein structure analyses predicted
the existence of multiple hydrophobic moieties, suggesting that the Us18, US19, and Us20 polypeptides were
transmembrane proteins. The major transcription initiation site, determined by primer extension and S1
nuclease mapping, for the 2.85-kb transcript was located right at the first initiation codon of the Us20 ORF.
There was no typical TATA box or CAAT box upstream of the 2.85-kb mRNA cap site except for a TATAAGA
sequence that was found about 210 bp downstream from the major cap site. The 1.1-kb transcript was initiated
33 bp upstream of the Us18 translation initiation site, and an atypical TATA box sequence (GATAAGA) was
found 22 bp upstream of the transcription start site. Differences in transcription kinetics and sensitivities to
metabolic inhibitors suggest that they were regulated by different mechanisms; the 2.85-kb mRNA belongs to
the early (13) class of transcripts, while the 1.1-kb mRNA is a late ('y) message. Subgenomic DNA segments
derived from the Us18, Us19, and Us20 ORFs were subcloned and overexpressed in Escherichia coli as fusion
proteins with glutathione-s-transferase. Western immunoblot analysis with antibodies against the Us18, Us19,
and Us20 fusion proteins detected virus-specific polypeptides with molecular sizes of 36, 32, and 43 kDa,
respectively. All three antibodies also exhibited a positive immunofluorescence reaction with human cytomeg-
alovirus-infected cells harvested at late stages of infection.
Human cytomegalovirus (HCMV) is the fourth herpesvi-
rus to be sequenced and has the greatest genomic complexity
among the human viruses discovered to date (3). The viral
genome is a double-stranded DNA 230 kb in length. More
than 200 open reading frames (ORFs) can be derived from
this viral genome (3). Like that of herpes simplex viruses,
the HCMV genome is composed of a unique long (UL) and a
unique short (Us) segment, each bounded by terminal re-
peats that permit UL and Us inversions to form four isomeric
molecules (9, 13, 14). The HCMV Us region is very different
from that of other human herpesviruses. The 38-kb Us
region of HCMV contains at least six families of homologous
ORFs, and except for the G protein-coupled receptor (GCR)
family, none of these show homology to other known human
herpesviruses ORFs (25). Each family contains 2 to 13
members or ORFs which occur either as tandem arrays (the
Us2, Us6, and Us12 families) or dispersed in the Us region
(the Us1, Us22, and GCR families).
The Us2 family, composed of the Us2 and US3 ORFs,
produces a group of abundant immediate-early (IE) tran-
scripts encoding a group of putative membrane-associated
glycoproteins (24). The US6 family is composed of six
members, Us6 to Us11, which encode a group of early
transcripts (including two bicistronic mRNAs) for a group of
virion-associated envelope glycoprotein complexes, desig-
nated gCII (gp47-52 [6]). The Us22 family has 12 members,
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only 4 of which, Us22, Us23, Us24, and Us26, are located
within the Us region. This family encodes a group of early
viral proteins which contain N-linked glycosylation sites and
C-terminal charged residues but no obvious hydrophobic
transmembrane region. HCMV protein ICP22 was identified
as a member of this Us22 family. This protein is an early
viral protein predominantly localized in the nucleus but also
secreted into the culture medium from infected cells (15).
The GCR family produces membrane-spanning glycopro-
teins which have sequence homology with the opsin family
of cellular receptors (3). All three members of the GCR
family, Us27, Us28, and Us33, have seven potential mem-
brane-spanning regions. Members of this diverse family
transduce different signals in a variety of systems that have
roles in vision, olfaction, memory, learning, and regulation
of the circulatory system (16). Except for data obtained from
computer analysis of viral DNA sequences, there is little
information about the remaining two large gene families,
Usl and Us12. The Us12 family has 10 members (Us12 to
Us21), which are clustered and tandemly arranged between
the Us6 and Us22 families in the Us region. Members of this
family are grouped together by the characteristic of having
multiple hydrophobic regions within their products, which
are tentatively classified as membrane-associated proteins
with potential glycosylation sites. Each has up to seven
highly hydrophobic putative transmembrane regions. The
HCMV ORFs studied in this communication belong to this
family.
Most virus genes are monocistronic, encoding only one
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polypeptide in one gene. HCMV is an exceptions to this rule,
as polystronic messages are not uncommon in this human
herpesvirus. For example, pp65 and pp7l (UL82 and UL83)
are encoded by bicistronic genes in HCMV (3, 18). In this
communication, we show that the unique short region of
HCMV between 0.91 and 0.93 map units encodes a structur-
ally tricistronic gene for the US18, Us19, and Us20 polypep-
tides. Transcription of polycistronic genes in prokaryotic
organisms is regulated in a sequential manner. In general,
the coding region closest to the promoter regulatory region
produces more products. Therefore, at the beginning of this
study, we assumed that regulation of the transcription of this
HCMV tricistronic gene might be similar to that of a pro-
karyotic polycistronic gene. Northern (RNA blot) hybridiza-
tion, however, revealed two major mRNAs with different
transcription kinetics. Therefore, the transcriptional and
translational regulations of these messages were major sub-
jects for this study.
Sequence analysis of these three nonoverlapping ORFs
(transcription is leftward, from Us20 to Us18) predicted
three polypeptides of 342, 240, and 274 amino acid residues,
respectively. To verify whether these three ORFs are func-
tional and to confirm that this tricistronic gene is translated
in HCMV-infected cells, subgenomic DNA fragments of
these three ORFs were engineered and subcloned into a
bacterial expression vector containing the carboxy terminus
of the glutathione-S-transferase (GST) gene from Schisto-
soma japonicum under the control of a tac promoter, the
pGEX-GST system (21). These bacterially expressed fusion
proteins were used as antigens to prepare polyclonal anti-
bodies in rabbits for use in Western immunoblot and immu-
nofluoresence analyses.
MATERUILS AND METHODS
Virus, cells, and bacterial strains. Human embryonic lung
(HEL) fibroblasts (ATCC HEL 229; passages 15 to 24) were
used for propagation of the virus and all biochemical studies.
HEL cells were cultured in Eagle's minimal essential me-
dium supplemented with 10% fetal calf serum. The Towne
strain of HCMV (passage 34 to 39) was propagated in HEL
cells at a low multiplicity of infection (0.001 PFU/cell) for
seed stocks, and the virus titer was determined by a plaque
assay in HEL cells. For most experiments, HEL cells were
grown to near confluence in a culture flask and infected with
Towne strain HCMV at a multiplicity of infection of approx-
imately 2 PFU/cell. Virus absorption was carried out in a
CO2 incubator at 37°C for 2 h. Virus-infected cells were
harvested at the times indicated. Two bacterial strains were
used in these experiments. Eschenchia coli JM107 was used
in the propagation of plasmid DNA and M13 single-stranded
phage DNA template. E. coli Y1090 was used in the propa-
gation of Agtll cDNA clones (8).
Construction and screening of cDNA libraries. Total and
cytoplasmic RNAs were isolated from HCMV-infected HEL
cells at 72 h postinfection (p.i.) by the guanidinium isothio-
cyanate method (10). A cDNA library was constructed from
this RNA as described previously (8). Essentially, polyade-
nylated [poly(A)+] RNAs were purified by using oligo(dT)-
cellulose column chromatography. Double-stranded cDNA
was synthesized from poly(A)+ RNA by using oligo(dT) as
the primer. The cDNAs were methylated with EcoRI meth-
ylase before the EcoRI linker was added. After fractionation
through a Sepharose 4B column, cDNAs larger than 0.5 kb
were inserted into the EcoRI site of Xgtll and packaged in
vitro with packaging extracts obtained from Promega (Mad-
ison, Wis.) as described before (8). Two cDNA libraries with
1.5 x 106 and 2 x 106 recombinants were constructed from
total and cytoplasmic mRNA, respectively.
DNA labeling. The radioactive viral DNA probe was
labeled by the random-primed DNA labeling method (Ran-
dom Primer Labeling System U1110; Promega). To label the
5' termini of an oligonucleotide probe, 20 pmol of dephos-
phorylated oligonucleotides in an oligonucleotide kinase
buffer with 0.1 mCi of [_y-32P]ATP (3,000 Ci/mmol; Amer-
sham Corp.) and 4 U of T4 polynucleotide kinase was
incubated at 37°C for 30 min. After heat inactivation at 65°C
for 10 min, the labeled oligonucleotides were purified by
three rounds of ethanol precipitation.
Southern hybridization. Southern hybridizations were per-
formed by standard methods (20). Prehybridization was
carried out in a mixture containing 25 mM KPO4 (pH 7.4),
6x SSC (0.9 M NaCl, 0.09 M sodium citrate), 5 x Denhardt's
solution (0.1% Ficoll, 0.1% polyvinylpyrrolidone, 0.1% bo-
vine serum albumin), 50 ,ug of denatured salmon sperm DNA
per ml, and 0.1% sodium dodecyl sulfate (SDS) at 42°C for 6
h. After prehybridization, denatured 32P-labeled cDNA
probe (5 x 105 cpm/ml) was added and incubated at 42°C
overnight. Following hybridization, filters were washed
twice in lx SSC-0.1% SDS and twice in 0.25x SSC-0.1%
SDS at room temperature for 15 min each.
Northern hybridization. Total RNAs (8 ,g per well) pre-
pared from mock- and HCMV-infected HEL cells by guani-
dinium isothiocyanate cell lysis and cesium chloride equilib-
rium centrifugation were subjected to electrophoresis in a
1.2% agarose gel containing 6% formaldehyde and then
transferred to nitrocellulose as described before (10, 20). The
resulting filter was prehybridized at 42°C for 18 h and then
hybridized with a random-primed or nick-translated 32P-
labeled cDNA probe (5 x 105 cpm/ml) at 42°C for 24 h. After
being washed, the hybridized filter was autoradiographed
overnight at -70°C. The same blot was stripped of the
labeled probe by incubation at 90°C in TE buffer (10 mM
Tris-HCl [pH 7.5], 1 mM EDTA) for 15 min. The blot was
then hybridized with the 5'-end _y-32P-labeled antisense oli-
gonucleotides or a-32P-labeled cDNA probe for the yeast
28S rRNA gene. For the study of mRNA synthesis in the
presence of drugs, IE RNAs were prepared from cyclohex-
imide (50 ,ug/ml)-treated HEL cells harvested at 10 h p.i.
Early RNAs were prepared from phosphonoacetic acid (100
,ug/ml)-treated HEL cells harvested at 24 h p.i. Late RNAs
were harvested at 60 h p.i. without drug treatment.
DNA sequencing. cDNA and genomic DNA sequencings
were performed by the dideoxy chain termination method
(19), with the Sequenase kit from U.S. Biochemical Corp.
(Cleveland, Ohio) and Sequentide (NEG-034; New England
Nuclear, Boston, Mass.). Single- and double-stranded tem-
plates were obtained from appropriate subclonings in
M13mpl8 and mpl9. The enzymes used for the subcloning
include PvuII, RsaI, PstI, and XhoI. All sequences were
obtained and confirmed by sequencing data taken from both
strands. Eight synthetic oligonucleotides were used as se-
quencing primers to resolve sequence gaps and to confirm
sequence ambiguities. ORF analysis was carried out with the
DNA Inspector II (Textco, West Lebanon, N.H.). Two-
dimensional protein structures (4) and hydrophobicity and
hydrophilicity profiles of the deduced peptide were deter-
mined by using a software package provided by the Genetics
Computer Group (University of Wisconsin, Madison).
Primer extension. Primer extension experiments were per-
formed by the method described by Kingston (11), with
minor modification. Four 30-bp oligonucleotides, including
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primer 517 (5'-ACACAAGCGAGCGAGTGGGGCACGGT
GACG-3') and primer 520 (5'-CCACTCGAGAGCCTCCAT
GCGGGAGAGCAG-3'), both complementary to the 2.85-kb
message, and primer 130 (5'-TGTTCGGAAACCGAGGCG
GTGTCGCCATGC-3') and primer 136 (5'-TCGGCCACC
AGCGCGTGGCTGCGATGGAGC-3'), both complemen-
tary to the 1.1-kb message, were synthesized on an Applied
Biosystems synthesizer and end labeled with [,y-32P]ATP by
using T4 polynucleotide kinase. Seven micrograms of total
RNA and 104 cpm of labeled primers were mixed for 5 min at
80°C and then precipitated with alcohol. Pellets were dis-
solved in 20,1 of lx hybridization buffer [80% formamide,
40 mM piperazine-N,N'-bis(2-ethanesulfonic acid) (PIPES,
pH 6.4), 400 mM NaCl, 1 mM EDTA] and allowed to anneal
at 30°C overnight. After ethanol precipitation, reverse tran-
scriptase extension reactions were carried out at 42°C for 90
min. These were done in a final volume of 25,u containing 18
U of avian myeloblastosis virus reverse transcriptase, 50
mM Tris-HCl (pH 8.0), 5mM MgCl2, 5 mM dithiothreitol, 50
mM KCI, 50 U of RNasin, and 50 ,uM each of the four
deoxynucleoside triphosphates. After RNase digestion, phe-
nol extraction, and ethanol precipitation, the pellets were
dissolved in 4 RI of TE and 4 RI of gel loading buffer, heated
at 80°C for 3 min, and loaded on a 6% polyacrylamide
sequencing gel containing 7 M urea. The extension products
were analyzed by comparison with genomic DNA sequenc-
ing reactions, which were run in parallel. The control
genomic DNA was derived either from a 1,008-bp (bp 3 to
1010) NcoI-PstI fragment upstream of the 2.85-kb mRNA or
from a 602-bp (bp 1722 to 2333) PvuII-PvuII fragment
upstream of the 1.1-kb mRNA.
S1 nuclease mapping. The four oligonucleotides used in
primer extension were also used in S1 nuclease mapping (1).
Primer 517 and primer 520 were used for the 5'-end mapping
of the 2.85-kb message. Primer 130 and primer 136 were used
for the 5'-end mapping of the 1.1-kb messages. The proce-
dure used was as follows: 5'-end-labeled oligonucleotides
were annealed to single-stranded templates derived from the
corresponding NcoI-PstI region (for the 2.85-kb message) or
PvuII-PvuII region (for the 1.1-kb mRNA), extended with
Klenow enzyme, and restricted to generate uniform restric-
tion fragments. A polyacrylamide gel electrophoresis-puri-
fied probe (2 x 104 cpm) was annealed to 10 ,ug of total RNA
in 30 RI of hybridization buffer (80% deionized formamide,
0.4 M NaCl, 10 mM PIPES [pH 6.5], 1 mM EDTA). This
annealing mixture was placed in a 55°C water bath for 5 min
and then incubated at 30°C for 16 h. To the annealed
mixture, 200 jil of S1 buffer (30 mM sodium citrate [pH 4.5],
0.25 mM NaCl, 1 mM ZnSO4, 5% glycerol) and 100 U of S1
nuclease were added. The mixture was incubated at 16°C for
1 h. The S1 nuclease-resistant fragments were precipitated
with ethanol, denatured in 4 jI of formamide sample buffer
(90% formamide, 0.1% bromophenol blue, 0.1% xylene
cyanol), and electrophoresed in a 6% polyacrylamide se-
quencing gel with 7 M urea. The nuclease-resistant products
were analyzed by comparison with genomic DNA sequenc-
ing reactions run in parallel.
Overexpression of US18, US19, and Us20 in the pGEX-GST
system. The GST gene fusion system was used to express
viral DNA subclones as fusion proteins (21). To construct
in-frame clones, DNA fragments were inserted into the
BamHI and EcoRI sites of one of three expression plasmids,
pGEX-1N, -2T, or -3X (21), with the reading frame matched
in the sense orientation to yield recombinant plasmids
pGEX-lN-US18, pGEX-lN-US19, and pGEX-3X-US20.
Overnight cultures of plasmid-transformed E. coli JM107
were diluted 1:10 with fresh medium and grown at 37°C for
1.5 h. They were subsequently induced with isopropyl-3-D-
thiogalactopyranoside (IPTG) at a final concentration of 0.1
mM. After 1 to 6 h of growth, cells were pelleted and lysed
in 0.25 volume of SDS sample buffer (0.006 M Tris-HCl [pH
6.8], 4% SDS, 40% glycerol, 3% dithiothreitol, 0.005%
bromophenol blue). The samples were boiled and subjected
to 12% polyacrylamide gel electrophoresis.
The majority of the US18-GST, Us19-GST, and US20-GST
fusion proteins were expressed as insoluble inclusion bodies.
The inclusion bodies were prepared as described by Harlow
and Lane (7) with modification. In brief, the induced plas-
mid-transformed E. coli JM107 cultures (pGEX-1N-US18,
pGEX-lN-US19, and pGEX-3X-US20, respectively) were
pelleted by centrifugation at 8,000 x g for 5 min. The cell
pellets were washed twice and resuspended at 1/10 their
original volume in a washing buffer containing 100 mM
NaCl, 1 mM EDTA, and 50 mM Tris-HCl (pH 8.0). Ly-
sozyme was added to the suspension at a concentration of 1
mg/ml, and the suspension was incubated at room tempera-
ture for 20 min. The lysate was then sonicated for three 30-s
cycles at full power with a Branson Sonifier (model 200 cell
disrupter) equipped with a microtip and centrifuged at 5,000
x g for 10 min. The supernatant containing soluble fusion
protein was further purified on a glutathione-Sepharose
column. The pellets containing inclusion bodies were
washed with an ice-cold washing buffer (100 mM NaCl, 1
mM EDTA, 50 mM Tris-HCl [pH 8.0]) with 0.1% SDS, then
with washing buffer containing 1% Nonidet P-40, and finally
with washing buffer alone. The inclusion bodies were then
further purified by 10 to 50% sucrose gradient centrifugation.
Fractions containing inclusion bodies were pelleted and
resuspended in phosphate-buffered saline (PBS), analyzed
for purity, and used as antigens for antibody production in
rabbits.
Antibody preparation. Antisera against the US18-GST,
Us19-GST, and US20-GST fusion proteins were made by
individually immunizing New Zealand White rabbits. Inclu-
sions with fusion protein aggregates were denatured in the
presence of 7 M guanidine HCI solution and dialyzed against
PBS with several changes of buffer solution to remove the
guanidine HCl. A mixture of 100 jig of the fusion proteins
with an equal volume of Freund's complete adjuvant (Cal-
biochem Corp.) was injected into the rabbits subdermally at
multiple sites near the hind legs. Booster injections with
fusion proteins in an equal volume of Freund's incomplete
adjuvant (Calbiochem Corp.) were given intradermally to the
rabbits three times at three-week intervals. Ten days after
the final injection, rabbits were bled, and the sera were
tested for the presence of HCMV-specific antibodies by
Western blot analysis and immunofluorescence staining.
Western blot and indirect immunofluorescence analysis.
HEL cells were infected with HCMV as described above. At
the indicated times, cells were washed twice with ice-cold
PBS and then lysed with 2x SDS sample buffer (0.125 mM
Tris [pH 6.8], 20% glycerol, 0.2% SDS, 0.28 M 3-mercap-
toethanol, 10 jig of bromophenol blue). The lysates were
sheared by passage through a 20-gauge needle four times and
then boiled for 5 min. After electrophoresis, proteins were
transferred to nitrocellulose paper in transfer buffer (20 mM
Tris-HCl [pH 8.0], 150 mM glycine, 20% methanol). The blot
was washed three times with blocking buffer (2% dry milk in
PBS) at room temperature for 10 min each and then probed
with antiserum against the fusion protein (diluted 1:100 in
blocking buffer) at room temperature for 1 h. The antiserum
was removed, and the blot was rinsed three times with a
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FIG. 1. Physical map of HCMV Towne strain DNA and relative locations of the EcoRI D fragment, cDNAs, and various transcriptional
products derived from this tricistronic gene. (A) Fractional map of the HCMV DNA genome. (B) Schematic representation of the HCMV
genome, with the restriction map for EcoRI. (C) EcoRI D fragment of the HCMV genome, designated pHD4 (5). The transcription orientation
of the 2.3-kb cDNA is indicated by an arrow, and the magnified map is shown underneath. (D) Transcripts and relative locations of DNA
primers used for primer extension and S1 mapping. (E) Schematic diagram showing locations of the 2.85-kb and 1.1-kb mRNAs and cDNAs
and their locations relative to transcription initiation sites. A 628-bp sequence was missing in the 2.3-kb cDNA and an 81-bp sequence was
missing in the 1.1-kb cDNA compared with their mRNAs. (F) The location and arrangement of putative gene products. Data were obtained
from the experiments shown in Fig. 2 through 8.
blocking buffer. Bound antigen-antibody complexes were
detected by incubating the filter in buffer solution with
protein A-peroxidase-labeled secondary antibody (Boehr-
inger Mannheim Co.) at a 1: 500 dilution for 2 h. After
incubation, the filter was washed as above and reacted with
substrate (10 mg of diaminobenzidine in 100 ml of PBS with
10 ,ul of 30% H202) for 30 min.
For the indirect immunofluorescence test, antibodies were
preabsorbed with HEL cellular lysates at 37°C for 1 h.
HCMV-infected HEL cells grown on eight-well chamber
slides (Nunc, Naperville, Ill.) were harvested at the indi-
cated times p.i. The cells were washed with PBS three times
and fixed with ice-chilled methanol-acetone (1:1) at -20°C
for 15 min. The fixed cells were then blocked with 20%
normal goat serum (Jackson Immuno Research Laboratory
Inc.) in PBS for 30 min at room temperature. Cells were then
reacted with diluted rabbit antiserum (1:50 in PBS) for 1 h.
After PBS washes, biotin-labeled goat anti-rabbit immuno-
globulin G secondary antibodies (Vector Laboratories Inc.,
Burlingame, Calif.) at a 1:200 dilution were added to the
cells and incubated at room temperature for 1 h. After a PBS
wash, fluorescein-conjugated avidin D (Vector Laboratories
Inc.) was added at a concentration of 12.5 ,ug/100 ml. The
slide was mounted with 50% glycerol in PBS and examined
under a fluoresent microscope.
Nucleotide sequence accession number. The GenBank ac-
cession number for the sequence reported in this communi-
cation is L04998.
RESULTS
cDNA cloning. In our first attempt to isolate EcoRI D
fragment-related sequences, a 2.3-kb cDNA was isolated
from our Xgtll cDNA library made from HCMV-infected
fibroblasts. This 2.3-kb cDNA was mapped in the EcoRI D
fragment. The mapping was done by Southern hybridization
and further confirmed by DNA sequence analysis at both
ends of the 2.3-kb cDNA, as shown below (Fig. 1). In
subsequent screenings with the 2.3-kb cDNA clone as the
probe, 80 positive clones were isolated from 4 x 104 recom-
I
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FIG. 2. Transcription analysis with the 2.3-kb cDNA and strand-specific oligonucleotide probes. Total RNA (8 pLg per well) was prepared
from mock- and HCMV-infected HEL cells. Cytoplasmic, nuclear, and total RNAs were purified from HEL cells at 60 h p.i. Cytoplasmic and
nuclear RNAs were further fractionated by oligo(dT)-cellulose column chromatography to obtain poly(A)' mRNA. Sizes are indicated on the
left, and arrows on the right indicate the messages detected and their sizes (in kilobases). (A) Probed with a strand-specific probe (primer 136)
close to the 3' end. Two messages, 2.85 and 1.1 kb, were observed. (B) Probed with a strand-specific probe (primer 520) close to the 5' end
of the 2.85-kb mRNA. This probe detected only one message of 2.85 kb (see Fig. 1 for relative locations of oligonucleotide probes used in
hybridization studies). (C) Probed with labeled 2.3-kb cDNA. This probe detected 2.8-kb, 1.1-kb, and a minor 1.8-kb message.
binant phages. Twenty positive clones were analyzed by
restriction enzyme mapping and DNA sequencing. The
clones were categorized into three groups, with a cDNA
insert of 2.3, 1.8, and 1.1 kb, respectively. Three cDNA
clones were further cloned into M13mpl8 for 3'-end and
5'-end analysis. The results of 3'-end analysis reveal that the
2.3-kb, 1.8-kb, and 1.1-kb cDNAs have an identical poly-
adenylation signal (AATAAA) and a 14-bp downstream
sequence (GCTTT1TT1-1CACGCTl) and are 3' coterminal.
Transcription pattern. To analyze the transcripts corre-
sponding to the 2.3-kb cDNA, RNA samples isolated at 60 h
after infection were probed with the nick-translated and
random-primed labeled 2.3-kb cDNA fragment. Two major
groups ofmRNAs of 2.85 and 1.1 kb were detected (Fig. 2C).
The detection of a minor band of 1.8 kb was not consistent
and varied from batch to batch of RNA preparations. Hy-
bridization with an antisense oligonucleotide probe (primer
520) derived from the 5' end of the 2.3-kb cDNA detected the
2.85-kb message but not the 1.1-kb transcript (Fig. 2B).
When an antisense oligonucleotide probe (primer 136) de-
rived from the 3' end of the 2.3-kb cDNA was used as the
probe, both the 2.85-kb and the 1.1-kb messages were
detected (Fig. 2A). This result suggests that the 1.1-kb
transcript was transcribed within the 3'-end portion of the
2.85-kb message. The DNA sequence between the poly(A)
signal sequence and the 5' end of the 1.1-kb cDNA was
equivalent to the length detected in the 1.1-kb RNA tran-
script. These data suggest that the 2.85-kb and 1.1-kb
mRNAs are 3' coterminal and that the 1.1-kb transcript is
unspliced. These 3'-coterminal transcripts were further con-
firmed by 3'-end sequencing of the cDNA as well as by the
method of the rapid amplification of the cDNA ends (RACE)
(data not shown).
5'-end mapping by primer extension and Si nuclease map-
ping. Two antisense oligonucleotides (primer 517 and primer
520), complementary to two areas close to the 5' end of the
2.85-kb mRNA, were used in the primer extension studies
(data not shown). Both of these primers showed the same
major transcription initiation site right at the translation
initiation codon of the Us20 ORF, even though these two
primers are 80 bp apart. These two oligonucleotides were
also used in Si nuclease mapping. The major transcription
initiation site for the 2.85-kb mRNA was similar to the
primer extension site (Fig. 3A). However, when primer 517
was used for S1 nuclease mapping, a minor band also
appeared about 243 bp downstream from the major initiation
site indicated above, which is approximately 26 bp down-
stream from a putative TATA box and approximately 21 bp
upstream of a potential second initiation codon for the Us20
ORF (data not shown).
Another set of antisense oligonucleotides (primer 130 and
primer 136), complementary to the 5'-end region of the
1.1-kb mRNA, were used in the primer extension studies to
detect the transcription initiation site of the 1.1-kb mRNA.
This set of primers picked up four transcription initiation
sites with equal intensity within a 7-base range (data not
shown). S1 nuclease mapping with the same oligonucleotides
also detected a major transcription initiation site in the same
region (Fig. 3B). This site was 33 bp upstream of the Us18
translation start site. The 5' end of this transcript has a
TATA-like box, GATAAGA (bp 2115 to 2121), 22 to 28 bp
upstream of the transcription initiation site. A CAAT-like
box, CGTCAATCA (bp 2085 to 2092), was 50 to 58 bp
upstream of the transcription initiation site. The transcrip-
tion initiation site was 33 bp upstream of the Us18 transla-
tion initiation codon. The schematic diagrams in Fig. 1E and
F outline the transcription initiation sites found and their
relative locations in the cDNAs. The details are indicated in
Fig. 6.
Attempts to map the 5' end of the minor 1.8-kb mRNA
were not successful when primer 156 (5'-GTAGCAGCAG
GAACA-3') was used for primer extension and S1 nuclease
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FIG. 3. Si nuclease mapping of the 2.85-kb and 1.1-kb messages. The 5'-end-labeled oligonucleotides (primer 520 for the 2.85-kb mRNA,
and primer 136 for the 1.1-kb mRNA) were annealed to corresponding sense single-stranded DNA templates for the synthesis of 32P-labeled
antisense probes. The preparation of radioactive single-stranded DNA fragments and the procedure for S1 mapping are described in Materials
and Methods. The dideoxynucleotides (T, G, C, and A) used in the reactions are shown above the lanes. The DNA sequencing data from
parallel experiments are shown to the left of each panel; possible transcription initiation sites are marked with asterisks (*). (A) Si mapping
of the 2.85-kb mRNA. Late RNA (L) isolated at 60 h p.i. was used in this analysis. (B) Si mapping of the 1.1-kb mRNA. RNAs isolated at
24 (E) and 60 (L) h p.i. were used in this study. The transcription initiation site is indicated by an arrow and marked by an asterisk (*) in the
sequence.
mapping, perhaps because of the low transcription level of
this message.
3'-end mapping by cDNA sequencing and RACE. In order
to further verify that these mRNAs were 3'-end coterminal,
two different methods were used: sequencing different
batches of cDNA, and RACE. Twenty positive cDNA
clones were sequenced at both ends, and the sequence
results indicated that these three groups of cDNA (2.85, 1.8,
and 1.1 kb) use the same polyadenylation signal (AATAAA),
which is 15 bp upstream of the poly(A) tail. On the other
hand, these three cDNAs have different lengths of poly(A)
tail. The results of the RACE experiment revealed a single
band of 290 bp, the predicted size. Subsequent sequence
analyses of this RACE-amplified DNA fragment further
verified the results (data not shown). Both the cDNA se-
quence and RACE amplification provide supporting data
for 3'-end cotermination of the major 2.85-kb and 1.1-kb
mRNAs and the minor 1.8-kb mRNA.
Analysis of transcription patterns. Total RNAs collected at
different time points (0, 4, 8, 12, 24, 48, 60, and 72 h p.i.)
were electrophoresed through a 1.2% agarose gel containing
6% formaldehyde and analyzed by Northern hybridization.
The transcription patterns were derived from the use of two
antisense oligonucleotide probes, one from the 5' end of the
2.85-kb mRNA and another from the 3' end of both tran-
scripts. The 5'-end probe detected only the 2.85-kb mRNA
(Fig. 4), while the 3'-end probe detected both the 2.85-kb and
1.1-kb messages (Fig. 4B). RNA levels were quantitated by
densitometer scanning and normalized to that of the internal
control, rRNA. Transcription of the 2.85-kb mRNA first
appeared at 12 h p.i., reached a maximum level at 48 h p.i.,
and then gradually decreased. The 1.1-kb mRNA appeared
between 24 and 48 h p.i. and remained at a constant level
until 72 h p.i. (Fig. 4C). The increase in transcription at 96 h
p.i. was probably due to virus reinfection.
Transcription pattern in the presence of drugs. To further
characterize these two mRNAs, the transcription patterns
were studied in the presence of protein and viral DNA
synthesis inhibitors. In the presence of the protein synthesis
inhibitor cycloheximide (50 ,ug/ml), both the 2.85-kb and
1.1-kb transcripts became undetectable (Fig. 5). These data
suggested that the 2.85-kb and 1.1-kb messages might re-
quire HCMV IE gene products for the initiation of their
transcription. Therefore, we conclude that these two mes-
sages were not IE transcripts.
In the presence of phosphonoacetic acid (100 ,ug/ml), a
viral DNA synthesis inhibitor, the 2.85-kb mRNA accumu-
lated to a level comparable to that in the control (without
drug) at 60 h p.i. The transcriptional level of the 1.1-kb
message in the presence of phosphonoacetic acid, however,
decreased to less than one-fifth of control levels (Fig. 5).
These data suggest that the 2.85-kb mRNA is actually an
early, or a-type, message of HCMV, which did not require
viral DNA replication for expression. The 1.1-kb mRNAwas
expressed at late times during infection (24 to 48 h p.i.) and
required viral DNA replication for maximum expression; it
is clearly a late, or -y-type, message. The results show that
these two transcripts were expressed at different times after
infection and were regulated by different mechanisms.
Computer analysis of DNA sequence. A 3,158-bp DNA
sequence (Fig. 6) was assembled from the sequencing data



























STRUCflURALLY TRICISTRONIC GENE OF HCMV 2049
MW. mock 4 8 12 24 48 60 72 96(Kb;f


















FIG. 4. Transcription pattern analysis of the 2.85-kb and 1.1-kb
mRNAs by Northern blot hybridization. Total RNA was prepared
from mock- and HCMV-infected HEL cells at various times (0, 4, 8,
12, 24, 48, 60, 72, and 96 h p.i.) as indicated above each lane. Eight
micrograms of total RNA was subjected to electrophoresis through
a 1.2% agarose gel containing 6% formaldehyde and then transferred
to nitrocellulose paper. (A) The resulting filter was probed with an
antisense oligonucleotide primer located at the 5' end of the 2.85-kb
mRNA (see Fig. 1D, primer 520). (B) The filter was reprobed with an
antisense oligonucleotide primer (primer 136) located at the 3' end of
both mRNAs. (C) The blot was probed with yeast rRNA as an
internal control. The arrows on the right indicate the messages
detected, and the arrows on the left indicate the positions of size
markers (in kilobases).
restricted genomic or cDNA fragments with an M13mpl8
subcloning system and primer extension approach. This
DNA sequence includes a 2,290-bp cDNA fragment and a
1,008-bp genomic region upstream of the 5' end of the 2.3-kb
cDNA. These two DNA fragments overlap tail to head, with
140 bp at the 3' end of the 1,008-bp upstream genomic region
and at the 5' end of the 2,290-bp cDNA sequence. ORF
analyses of the sequences shown in Fig. 1F and Fig. 6 were
done with the DNA Inspector II program. Three indepen-
dent nonoverlapping ORFs of Towne strain HCMV, equiv-
alent to Us18, Us19, and Us20 of AD169 strain HCMV,
were derived. A typical polyadenylation signal (AATAAA,
bp 3138 to 3143) was located 15 bp upstream of the common
poly(A) tail. All of these ORFs have a typical consensus
Kozak sequence (12) around the translation initiation codon.
Sequence comparison with AD169. The sequences of the
Towne and AD169 strains ofHCMV revealed 99.3% homol-
ogy. The Towne strain is an HCMV strain isolated from the
urine of a congenitally infected baby. The AD169 strain is a
prototype of HCMV isolated from adrenal glands almost 25
years ago that has been subcultured in vitro for more than
280 passages (17). The sequence comparison between these
two strains revealed 20 base mismatches (Fig. 6). No inser-
tions or deletions were found. Nine of the 20 mismatched
bases are located within noncoding regions. Ten of the 11
other single-base mismatches do not result in any amino acid
sequence alteration, and the other mismatch changes amino
acid residue 238 of Us20 from alanine in AD169 to valine in
FIG. 5. Transcription in the presence of protein and viral DNA
synthesis inhibitors. Eight micrograms of total RNA from mock- and
HCMV-infected cells treated with cycloheximide (CH; 50 p.g/ml) for
10 h or phosphonoacetic acid (PAA; 100 ±g/ml) for 60 h or untreated
cells at 60 h p.i. (LATE) was applied to each lane for Northern blot
RNA analysis. The resulting filter was probed with the 2.3-kb cDNA
probe. The arrows on the right indicate messages detected, and the
arrows on the left indicate the migration of size markers.
the Towne strain. The results of this experiment show that
the products of this tricistronic gene are very well con-
served.
Two-fdimensional protein structure analysis. Three ORFs
(US18, Us19, and Us20) were determined from DNA se-
quence analysis. Two-dimensional structure analysis of the
putative Us18 polypeptide reveals seven hydrophobic seg-
ments. Each is more than 20 amino acids long and may span
the cell membrane. One strong antigenic site was found
within one of the two potential glycosylation sites, where the
hydrophilic moiety is also obvious. The N-terminal end of
this peptide is hydrophilic, whereas the C-terminal end is
more hydrophobic. This ORF has 40 leucine residues among
274 amino acids. The putative Us19 polypeptide has only six
hydrophobic segments, but one of these is a long stretch of
50 hydrophobic amino acids. No potential glycosylation sites
were found in the US19 polypeptide, but two highly antigenic
clusters with hydrophilic moieties were found between the
first and the second and between the second and third
hydrophobic domains from the N-terminal side of this pep-
tide. Both the N- and C-terminal ends of this peptide are
hydrophobic. The putative peptide contains 52 leucines
among 240 amino acid residues. Two-dimensional structure
analysis of Us20 revealed seven hydrophobic segments, two
potential glycosylation sites, and two highly hydrophilic as
well as highly antigenic moieties located around amino acid
residues 50 and 250. The putative Us20 peptide contains 47
leucines among 342 amino acid residues. The hydrophobicity
profiles of these peptides show characteristics of membrane-
associated proteins: long stretches of hydrophobic amino
acids connected by a length of random coil or hydrophilic
amino acids.
Western blot analysis and indirect immunofluorescence
tests. Antibodies to the bacterially expressed fusion proteins
were able to react with virus-specific products in Western
blot analyses. The results obtained with HCMV-infected cell
lysates showed that anti-US18-GST antibodies detected a
36-kDa virus-specific band (Fig. 7A). This protein appeared
at 34 h p.i. and coincided with the late transcription of the
1.1-kb mRNA, a -y-class transcript. The Us19-GST antibody
detected a 32-kDa virus-specific peptide which appeared at a
_l _ - 2.85 Kb
_1.1 Kb
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FIG. 6. Nucleotide sequence of the structurally tricistronic gene encoding the 2.85-kb message and the putative polypeptides Us18, Us19,
and Us20. The 2,290-bp cDNA (2.3-kb cDNA) and 1,008 bp of genomic sequence located upstream of this cDNA were combined and are
shown in this figure with an overlap of 140 bp. Sequence mismatches between the Towne and AD169 strains are noted in the AD169 genomic
sequence. The polypeptide sequences are indicated below the DNA sequence. The transcription initiation sites identified by primer extension
and S1 nuclease mapping are indicated by solid bent arrows. The minor cap site for the 2.85-kb mRNA is also indicated. The beginnings of
the two cDNAs used in this study are also marked with open bent arrows. Upstream sequence analysis of the 2.85-kb and 1.1-kb mRNAs
revealed several indirect repeats (IR) and direct repeats (DR), which are numbered sequentially. Solid horizontal arrows indicate the IR and
open horizontal arrows indicate the DR upstream of US18 and Us20. The polyadenylation signal sequence and potential glycosylation sites
are underlined. The possible second translation initiation codon for Us20 is indicated by a bent arrow.
very low level at 18 h p.i. and was clearly demonstrated at 34
h p.i. (Fig. 7B). The anti-Us20-GST antibody detected a
major 43-kDa virus-specific product at 18 h p.i. (Fig. 7C).
This translation result also matched the 2.85-kb mRNA
transcription data. A minor band of 36 kDa was found at a
late time (34 h) in virus-infected lysates. This 36-kDa protein
might result from the use of the second translation initiation
codon at later stages of virus infection.
Antibodies generated in a rabbit against the bacterially
expressed fusion proteins (Us18-, Us19-, and US20-GST)
gave positive immunofluorescence staining in HCMV-in-
fected cells. This reaction was not found in mock-infected
cells or at 12 h after HCMV infection. The anti-Us18-GST
antibody detected positive immunofluorescence only at 48
and 72 h p.i. (Fig. 8). This result suggests that this virus-
specific product was translated at 48 h, which coincided with
the transcription data for the 1.1-kb mRNA. The Us19-GST
antibodies detected positive immunofluoresence at 24, 48, and
72 h p.i., with patterns similar to that with the anti-Us20-GST
antibody (data not shown). This result indicates that the Us19
virus-specific products appear earlier than the Us18 virus-
specific products. The US20-GST antibodies detected positive
immunofluorescent reactions at 24, 48, and 72 h p.i., like the
Us19-GST antibodies, but the reaction was stronger than it
was with the Us19-GST antibodies at 24 h p.i. (data not
shown). This result indicates that the Us20 virus-specific
products appeared earlier than the Us18 and US19 virus-
specific products. The early translation of the Us20 virus-
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Genomic repetition is a common characteristic of the
human herpesvirus group, but gene clusters in the Us region
are a unique characteristic in HCMV and herpes simplex
virus (3, 24). Before the HCMV genome had been com-
pletely sequenced, we originally speculated that the Towne
strain EcoRI D fragment located within the Us region
encoded the HCMV counterparts of herpes simplex virus gD
and gC. In our first attempt to screen for gD-related cDNA,
a 2.3-kb cDNA was isolated from a Xgtll cDNA library. This
cDNA has been used as a tool to characterize the corre-
sponding gene. To our surprise, instead of isolating gC or gD
homologs, we identified the US18, US19, and US20 tricis-
tronic gene.
In the study of the transcription products related to the
2.3-kb cDNA, two major messages (a 2.85-kb mRNA and a
1.1-kb mRNA) and a minor 1.8-kb mRNA were identified.
Detection of the minor message by the 2.3-kb cDNA probe
was not consistent, varying from one preparation to another.
From DNA sequencing and ORF analysis, the minor 1.8-kb
product might be derived from the second ORF, which does
not have a strong classical promoter-enhancer sequence and
might require special cellular or viral products for maximal
expression. The expression of this group of messages might
be under very tight control. The presence of the 1.8-kb
cDNA reflects the existence of this weak message. Mean-
while, the detection of 2.85-kb mRNA suggested that the
2.3-kb cDNA is not a full-length cDNA, since approximately
628 bp of the 5' upstream sequence was missing. Also, the
1.1-kb mRNA could represent the 1.1-kb cDNA.
As determined by primer extension, the 2.85-kb mRNA
has two transcription initiation sites; one is right at the first
translation initiation codon of the US20 ORF, and the other
is 243 bp downstream from the first site. There is a typical
TATA sequence (TATAAGA) 21 bp upstream of the first
transcription initiation site, but no typical CAAT sequence
was observed. There were two GC boxes and a direct repeat
located about 40 to 80 bp upstream of this typical TATA box.
On the other hand, no typical TATA [TATA(A/T)A(AJT)]
box or CAAT [GG(C/T)CAATCT] box upstream of the
second cap site was found. It is unclear why the major
transcription initiation site for the 2.85-kb mRNA is located
right at the first translation initiation codon of Us20. In
general, leader sequences are 20 to 100 nucleotides long on
most vertebrate mRNAs except for mRNAs derived from
proto-oncogenes, which have very long leader sequences
(12). In addition, the ATG codon is not well recognized when
it occurs close to the cap (12). Therefore, the translation
regulation of the Us20 ORF needs further investigation
before any conclusions can be made.
The transcription initiation site of the 1.1-kb mRNA was
33 bp upstream of the translation initiation site. In the region
upstream of this transcript, there is an atypical TATA box
sequence (GATAAGA) and an atypical CAAT box sequence
(CGTCAATCA) within 22 to 28 bp and 50 to 58 bp upstream
of the cap site, respectively. Promoter activity upstream of
the 2.85-kb mRNA was detected during HCMV infection
(data not shown). The promoter activity of the region
upstream of the 1.1-kb mRNA is still under investigation.
With regard to the Us19 ORF, there are typical TATA and
GC boxes upstream of the translation initiation site and a
minor 1.8-kb mRNA which could correspond to a transcript
initiating near these potential transcription start sites. How-
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FIG. 7. Western blot analysis of HCMV-infected HEL cells with
anti-Us18-GST, anti-Us19-GST, and anti-Us20-GST antibodies.
DNA fragments corresponding to ORFs Us18, Us19, and Us20 were
isolated by restriction digestion and then subcloned into the pGEX-
GST gene fusion system for expression in E. coli (21). The fusion
proteins obtained were used to generate antibodies in rabbits for
immunological analysis of these peptides. HCMV-infected HEL
cells (2 x 105 cells) harvested at the times indicated above the lanes
(hours p.i.) were used for Western blot analysis. Arrows on the right
indicate virus-specific bands, and arrows on the left show the
positions of size markers (in kilodaltons). Antibodies derived from
the (A) Us18, (B) Us19, and (C) Us20 fusion proteins detected
virus-specific bands of 36, 32, and 43 kDa, respectively.
Sense-strand oligonucleotides targeting either the 5' end
or the 3' end of the 2.85-kb mRNA probes did not detect any
antisense messages transcribed from this genomic map re-
gion (data not shown). An antisense oligonucleotide (primer
136) targeting the 3' end of the 2.3-kb cDNA could detect
both the 2.85-kb and 1.1-kb messages. This result suggested
that these two messages were transcribed in the same
direction. The transcription pattern of this structurally tri-
cistronic gene is very similar to that of HCMV tegument
proteins pp65 and pp7l, in which two messages are tran-
scribed from the corresponding genomic region. A large
4.0-kb mRNA and a small unspliced 1.9-kb mRNA are
transcribed with a 3'-coterminal end. The pp65 matrix tegu-
ment protein is translated from a 4.0-kb mRNA, and the
pp7l high-matrix tegument is made from a 1.9-kb mRNA
(18).
Transcription kinetics were studied with RNAs harvested
at designated time points and after appropriate drug treat-
ment. These studies revealed that the 2.85-kb and 1.1-kb
mRNAs belong to two different classes of transcript. The
2.85-kb message is an early or ,-type mRNA which does not
require virus DNA replication for maximal expression. The
1.1-kb mRNA, expressed late (48 h p.i.) after virus infection
and requiring viral DNA replication for maximum expres-
sion, is a late or y-type message. This differential expression
occurs even though these transcripts are derived from the
same genomic map region and overlap at the 3' end. This is
common in the transcriptional regulation of early and late
HCMV mRNAs, in which early and late mRNAs are trans-
lated after immediate-early mRNAs (2, 5, 22, 23).
J. VIROL.
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FIG. 8. Indirect immunofluorescence study with antibodies against HCMV fusion proteins. The rabbit antibodies used in this study were
preabsorbed with HEL cellular lysates. (Inset a) Mock-infected HEL cells. (A to D) HCMV-infected HEL cells at 12, 24, 48, and 72 h p.i.,
respectively, were reacted first with the antibody against the fusion protein and then with biotin-conjugated goat anti-rabbit immunoglobulin
G antibody and stained with fluorescein-labeled avidin. Arrows indicate positive staining. Only results for Us18 are shown. Panels a, A, and
B were deliberately overexposed to show cell morphology.
The tricistronic 2.85-kb mRNA was transcribed after 12 h
p.i. and reached the maximum transcription level at 24 h p.i.
The first 5'-end translational product of the 2.85-kb mRNA,
the Us2O polypeptide, was detected at 18 h p.i., and its level
increased slightly over the infection period. The Us19
polypeptide could be detected at a very low level at 18 h p.i.,
but higher levels of Us19 were detected between 24 and 36 h
p.i. by immunofluorescence and Western blot analyses.
Transcription of the 2.85-kb mRNA decreased after it
reached its maximum level. In contrast, translation of this
message increased continuously over an extended period.
This result probably reflects the stability of the translation
products or an increase in the translation efficiency of the
2.85-kb mRNA at late stages of infection.
As pointed out above, a very minor 1.8-kb mRNA species
was inconsistently detected when the 2.3-kb cDNA was used
as a probe in Northern hybridization. Several attempts to
map transcription initiation by S1 mapping and primer ex-
tension failed. These results suggest that an extremely low
level of transcription, if any, of the 1.8-kb mRNA may occur
at the later stages of infection. This speculation is also based
upon the isolation of a 1.8-kb cDNA, derived from this
region, from the cDNA library of HCMV-infected cells. At
this time, we do not have definitive data to conclude whether
the 32-kDa US19 peptide is derived from the 2.85-kb or the
1.8-kb transcript. The 32-kDa Us19 peptide could barely be
detected at 18 h p.i. but was detected at a level comparable
to that of the 43-kDa Us20 peptide. If the stability and the
levels of translation efficiency are comparable between these
transcripts, then the level of mRNA for Us19 should be
comparable to that for Us20. Immunofluorescent staining of
the Us19 peptide indicated that it appeared as early as the
Us20 peptide, at 24 h p.i., but was less abundant than Us20.
From these data, we believe that the Us19 ORF may be
translated from the 2.85-kb mRNA. Expression of this ORF
may require a virus-induced factor(s) for maximal activity.
The monocistronic 1.1-kb mRNA was translated at a later
time p.i., and its translation subsequently remained constant
throughout the infection. This correlated well with the late
translation of the US18 virus-specific polypeptide.
Antibodies prepared against the three peptides, expressed
as fusion proteins, detected virus-specific proteins in
HCMV-infected cell lysates. The differences between the
sizes determined by Western blot analysis and the sizes
predicted from sequence analysis may be due to posttrans-
lational modification. These antibodies gave positive immu-
nofluorescence when tested during the late stages of HCMV
infection in HEL cells, but the virus neutralization assay
resulted in low neutralization activities. The low neutraliza-
tion activity of these antibodies could be due to inappropri-
ate folding of the fusion proteins or the lack of posttrans-
lational modification of these virus-specific products
expressed in E. coli. It is also possible that these proteins are
not essential for infectivity. Expression of these ORFs with
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a baculovirus vector in insect cells is under way for further
functional and antigenic studies.
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